May 20, 2022

Public workspaceShipping wastewater samples to FDA-CFSAN V.4

  • 1U.S. Food and Drug Administration
Icon indicating open access to content
QR code linking to this content
Protocol CitationMaria Balkey, Tina Lusk Pfefer 2022. Shipping wastewater samples to FDA-CFSAN. protocols.io https://dx.doi.org/10.17504/protocols.io.14egn797zv5d/v4Version created by Tina Lusk Pfefer
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License,  which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it’s working
Created: May 13, 2022
Last Modified: May 20, 2022
Protocol Integer ID: 62546
Abstract
This SOP provides guidance for shipping wastewater samples to the US FDA Center for Food Safety and Applied Nutrition (CFSAN), covering specific steps for registering samples with CFSAN and for the preparation of shipments (documentation, packaging, notifications). We recommend that samples are shipped in two batches, one batch after 3 months of sampling and one batch at the conclusion of your sampling (~6 months).
Before start
This protocol has three sections:
  • Section 1: Submission of metadata
  • Section 2: Preparation of Shipping supplies
  • Section 3: Sample shipment
Associated protocols:

Submission of metadata
Submission of metadata
  • Fill out the BioSample custom wastewater template (extension of NCBI's Generic SARS-CoV-2: wastewater surveillance, v1.0 ) according to the NCBI submission protocol for SARS-Cov-2 protocol, once completed, send it to covidtrakr@fda.hhs.gov for registration. Successful registrations will receive a notification confirming the sample registration, it will will include a list of CFSAN accessions.

Preparation of shipping supplies
Preparation of shipping supplies
Contact your Biosafety Officer at your institution and request instructions on how to ship wastewater samples. The samples shall be shipped according to Category B requirements at the least. Please follow the guidance from your institution for further shipping requirements.

For additional guidance on shipping according to Category B, please visit the APHL site below and navigate to the link to a PDF titled "Packing and Shipping Guidance for Biological Substances, Category B Specimens".
Make sure adequate shipping materials are available for the preparation of your package. Prepare your shipment according to your current SOPs, check your institution and courier guidelines for the shipping of dangerous goods (wastewater samples with SARS-Cov-2) before attempting any shipment.
Prepare the following documents for your package along your permits, government and/or institution requirements.
  • Spreadsheet with the list of samples and the description of shipment contents.
  • Any notes or comments regarding your package.
Label your samples accurately (tubes and caps). Each sample (200 mL minimum) must be labeled with a CFSAN accession provided after completion of the metadata registration. It is imperative to label containers so that the labels do not come off during shipment. It is strongly recommended that you use Cryo-babies Labels, use printed labels and secure them with transparent tape, or write directly on the container with permanent marker.
Wastewater samples shall be shipped in dry ice.
The outer packing must be labeled accordingly. The full name and address of the sender and recipient must be included.
Sample shipment
Sample shipment
Once all the above requirements are completed, ship by express/next-day air. Ship only on Monday, Tuesday, or Wednesday. Ship the isolates to the address included below.


U.S. FDA CFSAN
Attn: Christopher Grim/Maria Hoffmann
5001 Campus Drive
RM 4E009
College Park, MD 20740
Christopher.Grim@fda.hhs.gov
Maria.Hoffmann@fda.hhs.gov
Phone:240-402-1080 (Maria) or 240-402-3582 (Chris)


Email tracking number to covidTrakr@fda.hhs.gov. Include in the notification the number of samples shipped and the corresponding list of sample identifiers.
If you have doubts about any of these steps, please email covidTrakr@fda.hhs.gov.